...
机译:16Q24.3 4-基因mRNA签名预测无线电(化疗)治疗的头部和颈鳞状细胞癌的结果
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Helmholtz Zentrum Munchen Clin Cooperat Grp Personalized Radiotherapy Head Neuherberg Germany;
Helmholtz Zentrum Munchen Clin Cooperat Grp Personalized Radiotherapy Head Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Analyt Pathol Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Ludwig Maximilians Univ Munchen Inst Pathol Fac Med Munich Germany;
Helmholtz Zentrum Munchen Clin Cooperat Grp Personalized Radiotherapy Head Neuherberg Germany;
Ludwig Maximilians Univ Munchen Inst Pathol Fac Med Munich Germany;
Helmholtz Zentrum Munchen Clin Cooperat Grp Personalized Radiotherapy Head Neuherberg Germany;
Helmholtz Zentrum Munchen Clin Cooperat Grp Personalized Radiotherapy Head Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
Helmholtz Zentrum Munchen Res Unit Radiat Cytogenet Neuherberg Germany;
机译:16Q24.3 4-基因mRNA签名预测无线电(化疗)治疗的头部和颈鳞状细胞癌的结果
机译:β-霉素,Wisp1和TCF21预测头部和颈部局部晚期鳞状细胞癌患者的疾病特异性存活率和对无线电(化疗)治疗的初级反应
机译:Bmi-1和Podoplanin的共表达可预测接受放射(化学)疗法治疗的头颈部鳞状细胞癌患者的总体存活率。
机译:Zeste同源2的增强子的上调与Cyclin Dl过度表达和头颈部鳞状细胞癌的不良临床结果呈正相关。
机译:EIF5B在头部鳞状细胞癌(HNSCC)中的mRNA翻译调节
机译:放射(化学)疗法治疗的头颈鳞状细胞癌(HNSCC)中四个16q24.3基因的预后mRNA表达特征
机译:基于15 mRNA-lncrNA表达的签名预测了晚期术头和颈部鳞状细胞癌的存活